KDM1B Expression in Richardson Breast 2

Slides:

Advertisements

Similar presentations

Comparison of Selected Genes in Curtis Breast Grouped by Cancer and Normal Type log2 median-centered intensity 1. Breast (144) 2. Benign Breast Neoplasm.

Advertisements

1 Example of HMMs: copy number data. 2 DNA copy number is the number of copies of a genomic segment present in the cell. Copy numbers are measured in.

Comparative Genomic Hybridization (CGH). Outline Introduction to gene copy numbers and CGH technology DNA copy number alterations in breast cancer (Pollack.

Evaluating cell lines as tumor models by comparison of genomic profiles Domcke, S. et al. Nat. Commun 4:2126.

Proteomics Informatics – Data Analysis and Visualization (Week 13)

Cancer Estimated US Cancer Cases Cancer Incidence Rates for Women, USA.

Miki Fuse 1, Satoko Kojima 2, Takeshi Chiyomaru 3, Hideki Enokida 3, Kazumori Kawakami 3, Hirofumi Yoshino 3, Nijiro Nohata 1, Yukio Naya 2, Tomohiko Ichikawa.

OncomiR and tumor-suppressor miR expression in triple-negative primary breast cancer. Jelena Radojicic 1, Apostolos Zaravinos 2, Thomas Vrekoussis 1, Maria.

Maxwell Lee National Cancer Institute Center for Cancer Research High-dimension Data Analysis Group March 19, 2014 Integrated Studies Of Breast, Esophageal,

Microarray hybridization Usually comparative – Ratio between two samples Examples – Tumor vs. normal tissue – Drug treatment vs. no treatment – Embryo.

Have a positive role in cell division Have a negative role in cell division Have a role in the maintenance of DNA integrity Genes altered in cancer typically:

 We investigated for biomarkers that distinguish metastatic or recurring disease with non-metastatic disease, with a particular focus on breast cancer.

Date of download: 6/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Novel Integrative Methods for Gene Discovery Associated.

Supplementary Figure 1 Supplementary Figure 1. Representative micrographs of migration and invasion assays. miR-452 or si-WWP1 transfectants inhibited.

Supplemental Figure 1. Specificity of CCL2 and Fsp1 immunostaining of breast tumor tissues. Sections of invasive ductal carcinoma were incubated with primary.

Homozygous deletions within chromosome 9q23.

Volume 14, Issue 10, Pages (March 2016)

Cancer Genomics and Class Discovery

A B C ErbB3 protein levels ERBB3 mRNA levels P = P = 0.716

Lung squamous cell carcinoma

Figure 1. MORT gene silencing is early event in cancer

Figure S1. DCYTB expression is higher in ER+ than ER- patients

(A) Schematic diagrams demonstrating the HER2 mutational heterogeneity among and between cases of invasive breast cancer (n=963), bladder urothelial cancer.

The benefits and harms of breast cancer screening

The cBio Cancer Genomics Portal.

Fig. 8. Recurrent copy number amplification of BRD4 gene was observed across common cancers. Recurrent copy number amplification of BRD4 gene was observed.

Strategy Description Discovery Validation Application

Nat. Rev. Urol. doi: /nrurol

Kenneth G. Geles, Wenyan Zhong, Siobhan K

Frequency of JAK1 and JAK2 alterations and their association with overall survival in TCGA datasets. Frequency of JAK1 and JAK2 alterations and their association.

Plots derived from provisional TCGA data from sequencing and expression analyses of invasive breast carcinoma cases. Plots derived from provisional TCGA.

Volume 72, Issue 4, Pages (October 2017)

Intrinsic and acquired trastuzumab resistance.

Cysteine cathepsins (proteases)—On the main stage of cancer?

Volume 5, Issue 4, Pages e5 (October 2017)

Volume 29, Issue 5, Pages (May 2016)

Volume 31, Issue 2, Pages (February 2017)

Deletion of Lats1 is phenotypically distinct from Lats2 deletion in PyMT tumors. Deletion of Lats1 is phenotypically distinct from Lats2 deletion in PyMT.

Fig. 1. miR-370 was downregulated, and GUCD1 was upregulated in HCC

Volume 14, Issue 10, Pages (March 2016)

C.2.10 Sample Questions.

C.2.8 Sample Questions.

C.2.8 Sample Questions.

Dara S. Ross, Ahmet Zehir, Donavan T

Fig year-old woman with invasive ductal carcinoma of right breast

Fig year-old woman with invasive ductal carcinoma of right breast

Figure 1. Identification of differentially expressed messenger RNAs (mRNAs) in the The Cancer Genome Atlas (TCGA) BRCA database. (A) Heat map of the log2-fold.

FAK overexpression in invasive human breast cancer and DCIS

Measurement of Relative Copy Number of CDKN2A/ARF and CDKN2B in Bladder Cancer by Real-Time Quantitative PCR and Multiplex Ligation-Dependent Probe Amplification

Reduced BAI1 expression is associated with breast cancer patient survival. Reduced BAI1 expression is associated with breast cancer patient survival. A,

CHCHD2 and EGFR protein expression in NSCLC

PD-L1 is expressed in breast cancer.

B A F/36, Rt. breast palpable mass : invasive ductal carcinoma, HER-2 (+) (A) Indistinct margined, oval shaped, hyperdense mass in Rt. UIQ on MG Combined.

The Role of TIPE2 Protein in Invasive Breast Carcinoma

One-way hierarchical cluster analysis of SAM-identified genes using the TMEV software to see the data substructure. One-way hierarchical cluster analysis.

High-risk neuroblastoma molecular subtypes classification and inference of master regulators. High-risk neuroblastoma molecular subtypes classification.

Reduced number and impaired effector functions of TILs in tumors with PTEN deletion or loss-of-function mutations in PTEN. Cutaneous melanoma patients.

A and B, linearity of the preamplification step shown by a similar expression pattern of ERα mRNA in four breast tumor samples pre– and post–linear amplification.

Germline variants influencing primary tumor type.

A, heatmap of copy number alterations determined by array CGH for a panel of 79 frozen NSCLC samples. A, heatmap of copy number alterations determined.

Mutational signature analysis of WES data from patients with advanced PDAC. A, Projection of signatures representing four main mutational processes identified.

PTEN genotype frequently dictates PTEN expression status, but evidence of heterogeneous staining implies polyclonality within some ovarian tumors. PTEN.

The ovarian cancer cell lines modestly recapitulate the spectrum of mutations found in primary ovarian tumors. The ovarian cancer cell lines modestly recapitulate.

Recurrent tumor cell–intrinsic transcriptomic, RTKinomic, and immune regulomic alterations in regressing melanoma on MAPKi therapy. Recurrent tumor cell–intrinsic.

CASP8 mutations are associated with fewer CNAs and RAS family mutations. CASP8 mutations are associated with fewer CNAs and RAS family mutations. A, number.

Genomic instability is a core feature of ovarian cancer that frequently involves DNA-damage repair genes. Genomic instability is a core feature of ovarian.

Genomic and proteomic profiling of ovarian cancer cell lines.

Synthetic lethality of ROS1 inhibition in E-cadherin–deficient breast tumor cell lines. Synthetic lethality of ROS1 inhibition in E-cadherin–deficient.

Fig. 1. FAM83H over-expression is associated with poor prognosis of CC

Presentation transcript:

KDM1B Expression in Richardson Breast 2 P-value: 2.00E-9 Log2 median-centered intensity Ductal Breast Carcinoma Breast (7) (40) KDM1B Expression in TCGA Breast KDM1B Expression in TCGA Breast P-value: 1.67E-18 P-value: 3.38E-11 Log2 median-centered ratio Log2 median-centered ratio Invasive Ductal Breast Carcinoma Invasive Breast Carcinoma Breast Breast (61) (389) (61) (76) Oncoprint Altered in 107 (11%) of cases Case Set: All Tumors: All tumor samples (1002 samples) KDM1B 11% Amplification Homozygous Deletion mRNA Upregulation mRNA Downregulation Copy number alterations are putative